FDA Grants U.K. Firm Incentives to Develop Cannabis-Based Drug
U.S. regulators granted GW Pharmaceuticals’ cannabis-based epilepsy drug “orphan” status, enabling the company to receive tax credits and…
News April 25
Latest In: Finance
MedMen Inks $15M in Financing for California Expansion
MedMen, a cannabis management consultancy in Los Angeles, said it raised $15 million in venture financing and will…
News April 20AmeriCann Invests $6.7M in Massachusetts MJ Facilities
AmeriCann, a Denver medical marijuana company, is investing nearly $7 million in a dispensary and a grow facility in…
News April 14Report: Oregon Rec Sales Could Hit $300M
Oregon’s fledgling recreational cannabis industry could generate nearly $300 million in sales this year and $46 million in wages,…
News April 12Competition Bringing Down MMJ Prices in New Jersey
A pair of medical cannabis dispensaries that opened in New Jersey late last year have had a significant…
News April 11MassRoots Taking Another Stab at Nasdaq Listing
MassRoots, the popular social network for cannabis enthusiasts, is taking another shot at getting listed on the Nasdaq.…
News April 11CA Marijuana Software Startup Lands $2M Investment
A marijuana software company that aims to streamline business services for medical marijuana dispensaries and cultivators announced on…
News April 6Cannabis Branding Company Raises $8M for National Expansion
A marijuana branding company with a portfolio that includes partners in three western states announced on Tuesday that…
News April 5Oregon Governor Signs Marijuana Banking Bill
Oregon Gov. Kate Brown signed a bill Monday afternoon that protects financial institutions working with marijuana businesses from state…
News April 4
GW Pharmaceuticals Could Make Major Splash in U.S. Cannabis Industry
By Omar Sacirbey A British company that develops cannabis-based medicine is on the verge of a major breakthrough…
News March 30
Latest Sponsored
